- Use of high-intensity statin therapy for people under the age of 75 who have atherosclerotic cardiovascular disease. The goal should be to reduce their LDL by 50%.
- Use of moderate-intensity statin therapy in people aged 40 to 75 with diabetes. This should be done regardless of their 10-year risk of disease.
- Stick to the guiding principle that lower is better as far as LDL is concerned. Emphasise on the importance of a healthy living lifestyle - exercising and eating healthy. Blood pressure should be controlled, and smoking should be discouraged.
- Use of preventive treatment for people who might be at risk of disease. Ezetemibe should be the drug of choice in patients who have suffered a heart attack or have multiple high-risk conditions.
- Coronary artery calcium tests should be used in patients who are at intermediate risk and when a decision about statin therapy is uncertain. Statin therapy may be withheld if CAC is zero except in smokers, patients with diabetes and those with a strong history of premature ASCVD. It is interesting to note that coronary artery calcium scoring was deemphasised in the 2013 cholesterol guidelines but this changes with the new guidelines.
- Continuous monitoring cholesterol is encouraged, and it is recommended that patients on statin therapy should be assessed every 4 to 12 months.
#AHA18: Just in - new cholesterol management guidelines
Published on : Sat, 10 Nov 2018
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...